These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 32749639)
1. MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition. Ding X; Zhang J; Feng Z; Tang Q; Zhou X Dig Dis Sci; 2021 Jul; 66(7):2272-2282. PubMed ID: 32749639 [TBL] [Abstract][Full Text] [Related]
2. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer. Ma ZH; Shi PD; Wan BS Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196 [TBL] [Abstract][Full Text] [Related]
3. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4. Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453 [TBL] [Abstract][Full Text] [Related]
4. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356 [TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer. Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371 [TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression. Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214 [TBL] [Abstract][Full Text] [Related]
7. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Chang S; Sun G; Zhang D; Li Q; Qian H Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AGAP2-AS1 accelerates cell proliferation, migration, invasion and the EMT process in colorectal cancer via regulating the miR-4,668-3p/SRSF1 axis. Li H; Guo S; Zhang M; Li L; Wang F; Song B J Gene Med; 2020 Nov; 22(11):e3250. PubMed ID: 32639657 [TBL] [Abstract][Full Text] [Related]
9. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer. Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372 [TBL] [Abstract][Full Text] [Related]
10. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A. Wang D; Feng M; Ma X; Tao K; Wang G Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429 [TBL] [Abstract][Full Text] [Related]
11. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α). Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061 [TBL] [Abstract][Full Text] [Related]
13. Circ-MALAT1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR-506-3p/KAT6B axis. Yang FS; Gong SX; Qiu DD Kaohsiung J Med Sci; 2023 Sep; 39(9):862-872. PubMed ID: 37272875 [TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431 [TBL] [Abstract][Full Text] [Related]
15. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925 [TBL] [Abstract][Full Text] [Related]
16. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530 [TBL] [Abstract][Full Text] [Related]
17. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells. Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019 [TBL] [Abstract][Full Text] [Related]
18. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression. Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731 [TBL] [Abstract][Full Text] [Related]
19. DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer. Zhao G; Wang Q; Zhang Y; Gu R; Liu M; Li Q; Zhang J; Yuan H; Feng T; Ou D; Li S; Li S; Li K; Mo C; Lin P Cell Death Dis; 2023 Jan; 14(1):1. PubMed ID: 36593242 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1. Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]